Skip to main content

Find Clinical Trials

Home
Conditions
T-cell Lymphoma

Clinical trial condition

T-cell Lymphoma

Explore clinical trials studying T-cell Lymphoma. Study availability and eligibility vary by location and protocol.

34 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

T-cell Lymphoma trial results

Completed

A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma

NCT00322985

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

Cross Cancer Institute Edmonton, Alberta, Canada

Cancer Care Manitoba Winnipeg, Manitoba, Canada

Queen Elizabeth II, Health Services Centre Halifax, Nova Scotia, Canada

View Trial Details

Completed

Bendamustine in Patients With Refractory or Relapsed T-cell Lymphoma

NCT00959686

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Dr Gandhi DAMAJ Amiens, France

View Trial Details

Completed

Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma

NCT00161590

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Weill Medical College of Cornell University New York, United States

View Trial Details

Active, Not Recruiting

A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma

NCT03952078

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Stanford University Palo Alto, California, United States

University of Michigan Ann Arbor, Michigan, United States

Washington University St Louis, Missouri, United States

Hackensack University Medical Center Hackensack, New Jersey, United States

View all 22 locations

View Trial Details